Register to receive a free U.S. Market for ENT and Bronchoscopic Devices Report Suite report synopsis and brochure

According to a new series of reports on the U.S. market for ENT and bronchoscopic devices by iData Research (www.idataresearch.com), nose related procedures represented approximately 50% of the total ENT treatments in the United States. A large percentage of nose procedures are related to chronic sinusitis treatments. As many ENT procedures are elective, increased medical coverage and rising expendable incomes are helping the market grow. The continued shift to videoscopes and their higher average selling prices (ASP) will help maintain the ENT endoscope market and provide growth over the forecast period. The market for ENT endoscopes includes rigid scopes and flexible scopes.

The flexible scopes segment represents over 60% of the total ENT endoscope market. This market includes fiber optic and video flexible scopes. Rigid scopes have been losing market share over the past few years due to the increased preference towards flexible scopes. Although rigid scopes are not as widely applicable as flexible scopes, they are still a requirement in all ENT surgeons’ portfolios.

“The market value of endoscopes will experience limited growth and potential contraction as hospitals begin utilizing refurbished scopes in an effort to save costs,” explains Dr. Kamran Zamanian, CEO of iData. “Some manufacturers have reported as much as 50% of their unit sales come from the refurbished market.”

Although rigid scopes do not cover the range of procedures that flexible scopes do, there is still a significant market for these devices. The backbone of this market is the replacement of existing rigid scopes. Due to this replacement necessity, annual rigid scope unit sales are expected to exceed 13,500 for the foreseeable future. However, the increased prevalence of refurbished rigid scopes may have a negative impact on the overall market value, if not on the unit sales. Additionally, rigid scopes will be experiencing decreasing ASPs over the forecast period due to increased commoditization.

Olympus currently maintains the largest market share within the ENT endoscope market. This position is largely due to its dominance in the flexible endoscope market. Olympus is particularly strong within the growing flexible videoscope market, maintaining a majority of this market share through its ENF® and VISERA® product lines. Karl Storz is a close second in the ENT endoscope market. The majority of this is due to its strength in the rigid endoscope market. Additionally, Karl Storz will continue gaining market share through its popular HOPKINS® product line.

Pentax maintains a large share in the flexible endoscope market and is also well positioned through its offering of an ultrasound gastroscope in the EG line. Additional competitors in the ENT endoscope market include Cogentix, Richard Wolf, Teleflex, Acteon, BR Surgical and Ecleris, among others.

For Further Information
More on the ENT Endoscope market in the U.S. can be found in a report suite published by iData Research entitled the U.S. Market for ENT and Bronchoscopic Devices Report Suite. The suite covers reports on the following markets: ENT Endoscopes, ENT Powered Instruments, ENT Hand Instruments, ENT Radiofrequency Devices, Balloon Sinus Dilation Devices, Bronchoscopes, Bronchoscope Hand Instruments, Bronchial Stents, Bronchial Forceps, Transbronchial Aspiration Needles, and Foreign Body Removal Devices.

Reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about ENT and Bronchoscopic device market data or procedure data, register online or email us at [email protected] for a U.S. Market for ENT and Bronchoscopic Devices Report Suite brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch